BR0011721A - Polipeptìdeo, sequência de polinucleotìdeos, uso de um polipeptìdeo, processo para identificar compostos que inibem a atividade enzimática de um polipeptìdeo, e, uso de compostos - Google Patents

Polipeptìdeo, sequência de polinucleotìdeos, uso de um polipeptìdeo, processo para identificar compostos que inibem a atividade enzimática de um polipeptìdeo, e, uso de compostos

Info

Publication number
BR0011721A
BR0011721A BR0011721-8A BR0011721A BR0011721A BR 0011721 A BR0011721 A BR 0011721A BR 0011721 A BR0011721 A BR 0011721A BR 0011721 A BR0011721 A BR 0011721A
Authority
BR
Brazil
Prior art keywords
polypeptide
compounds
inhibit
polynucleotide sequence
enzymatic activity
Prior art date
Application number
BR0011721-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Neil T Dear
Thomas Bohm
Achim Moller
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of BR0011721A publication Critical patent/BR0011721A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR0011721-8A 1999-06-18 2000-06-07 Polipeptìdeo, sequência de polinucleotìdeos, uso de um polipeptìdeo, processo para identificar compostos que inibem a atividade enzimática de um polipeptìdeo, e, uso de compostos BR0011721A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19928021A DE19928021A1 (de) 1999-06-18 1999-06-18 Neue Calpaine und deren Verwendung
PCT/EP2000/005261 WO2000078933A2 (de) 1999-06-18 2000-06-07 Neue calpaine und deren verwendung

Publications (1)

Publication Number Publication Date
BR0011721A true BR0011721A (pt) 2002-03-05

Family

ID=7911777

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011721-8A BR0011721A (pt) 1999-06-18 2000-06-07 Polipeptìdeo, sequência de polinucleotìdeos, uso de um polipeptìdeo, processo para identificar compostos que inibem a atividade enzimática de um polipeptìdeo, e, uso de compostos

Country Status (18)

Country Link
EP (1) EP1185673A2 (no)
JP (1) JP2003503023A (no)
KR (1) KR20020011140A (no)
CN (1) CN1373808A (no)
AR (1) AR024573A1 (no)
AU (1) AU5970600A (no)
BG (1) BG106186A (no)
BR (1) BR0011721A (no)
CA (1) CA2375477A1 (no)
DE (1) DE19928021A1 (no)
HU (1) HUP0201800A2 (no)
IL (1) IL146940A0 (no)
MX (1) MXPA01012937A (no)
NO (1) NO20015922L (no)
PL (1) PL353004A1 (no)
SK (1) SK18262001A3 (no)
TR (1) TR200103662T2 (no)
WO (1) WO2000078933A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001016336A1 (en) * 1999-09-02 2001-03-08 Lexicon Genetics Incorporated Human calcium dependent proteases and polynucleotides encoding the same
CN102939126B (zh) 2010-04-30 2015-09-16 雅培心脏血管系统股份有限公司 呈现迅速膨胀和收缩的改进型球囊导管

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19737105A1 (de) * 1997-08-26 1999-03-04 Basf Ag Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung
WO2000058473A2 (en) * 1999-03-31 2000-10-05 Curagen Corporation Nucleic acids including open reading frames encoding polypeptides; 'orfx'

Also Published As

Publication number Publication date
JP2003503023A (ja) 2003-01-28
WO2000078933A2 (de) 2000-12-28
AU5970600A (en) 2001-01-09
AR024573A1 (es) 2002-10-16
BG106186A (bg) 2002-12-29
NO20015922D0 (no) 2001-12-04
SK18262001A3 (sk) 2002-09-10
WO2000078933A3 (de) 2001-07-26
TR200103662T2 (tr) 2002-05-21
PL353004A1 (en) 2003-09-22
NO20015922L (no) 2002-02-12
KR20020011140A (ko) 2002-02-07
MXPA01012937A (es) 2002-07-30
IL146940A0 (en) 2002-08-14
CN1373808A (zh) 2002-10-09
HUP0201800A2 (en) 2002-09-28
DE19928021A1 (de) 2000-12-21
EP1185673A2 (de) 2002-03-13
CA2375477A1 (en) 2000-12-28

Similar Documents

Publication Publication Date Title
EA199800913A1 (ru) Кальцилитические соединения
ES2105999T1 (es) Procedimiento para la preparacion industrial de fosfatidilserina.
EA200000251A1 (ru) Производные резорцинола
BG105112A (en) Agents with antidepressive effect
EA199800667A1 (ru) Новые фенантридины
EA200000351A1 (ru) Лечение кондуктивных нарушений
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
BR9713734A (pt) Derivados de sulfonamidas, processo para sua preparação, e seu uso como medicamentos
ES2059293T3 (es) Inhibidores de proteasas retrovirales.
ATE268379T1 (de) Enzym mit aminopeptidaseactivität
BR9306371A (pt) Composições refrescantes
DE68919618T2 (de) Entzundern von Walzgut.
DE59009945D1 (de) Mittel zur hemmung von hiv-proteasen.
DK0734380T3 (da) 4-Benzoylisoxazoler samt deres anvendelse som herbicider
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
BR0011721A (pt) Polipeptìdeo, sequência de polinucleotìdeos, uso de um polipeptìdeo, processo para identificar compostos que inibem a atividade enzimática de um polipeptìdeo, e, uso de compostos
DE59504918D1 (de) Direktziehendes haarfärbemittel
DE59808166D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum
PT83253B (pt) Processo para a preparacao de p-acilaminobenzamidas
PT968174E (pt) 2-aminotetralina opticamente activa processo para a sua preparacao e composicoes farmaceuticas contendo a mesma activas na prevencao e tratamento do choque septico
PL341597A1 (en) Agent containing a combination of active substances
BR9606955A (pt) Heterocicloalquenos substituísos
SV1994000064A (es) Derivados de acidos 1-(2-fluorciclopropil)-quinolon-naftiridon carboxilicos, ref.le a 29 869-sv.
ATE373475T1 (de) Carbamate von 2-heterozyklischen 1,2-ethandiolen
EA200200321A1 (ru) Апоптин-ассоциированный белок

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A, 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1927 DE 11/12/2007.